Literature DB >> 32717540

Clinical and imaging features of idiopathic granulomatous mastitis - The diagnostic challenges and a brief review.

Hemal Grover1, Shabnam Bhandari Grover2, Pradeep Goyal3, Rahul Hegde4, Sonali Gupta5, Saurabh Malhotra6, Shuo Li4, Nishant Gupta7.   

Abstract

Idiopathic granulomatous mastitis (IGM), or granulomatous lobular mastitis is a rare, benign, inflammatory condition of the breast, without an identifiable underlying etiology. The clinical and imaging diagnosis of this entity is challenging with the presentation frequently mimicking inflammatory breast carcinoma (IBC). Mammography and breast ultrasound (US) have an important role in its detection, however, biopsy is imperative for histopathological confirmation. We present three cases of biopsy proven IGM, highlighting the variability of the clinical and imaging features,brieflyreview the relevant literature and discuss the challenges associated with its diagnosis and management.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Breast ultrasound; Granular lobular mastitis; Idiopathic granulomatous mastitis (IGM); Imaging features; Mammography

Year:  2020        PMID: 32717540     DOI: 10.1016/j.clinimag.2020.06.022

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  3 in total

1.  Idiopathic Granulomatous Mastitis Presenting as Bilateral Breast Abscesses.

Authors:  Jesper Dierickx; Sofie Dekeyzer; Filip Vanhoenacker
Journal:  J Belg Soc Radiol       Date:  2021-12-21       Impact factor: 1.894

2.  The Effectiveness of Traditional Chinese Medicine Combined With Surgery to Treat Granulomatous Mastitis: A Propensity-Matched Analysis.

Authors:  Reziya Sawuer; Chunyu Wu; Zhenping Sun; Sheng Liu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 3.  Gynecomastia with rare granulomatous lobular mastitis: a case report and literature review.

Authors:  Liang Yin; Enock Adjei Agyekum; Qing Zhang; Ting Wu; Xiaoqin Qian
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.